Skip to content

Twist Bioscience Corporation TWST Other Income (Expense)

Other Income (Expense) at other companies

Danaher logo
DanaherDHR
-$73M+7.6%
Agilent Technologies logo
Agilent TechnologiesA
$21M+184%
Illumina logo
IlluminaILMN
-$52M-389%
TEC
Bio-TechneTECH
-$4.27M-884%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$4.2M-27.9%
Revvity logo
RevvityRVTY

Segments

By segment

See full
Reportable Segment$175K+144%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's other income (expense)?
Twist Bioscience Corporation (TWST) reported other income (expense) of $175K in Q1 2026.
How has Twist Bioscience Corporation's other income (expense) changed year-over-year?
Twist Bioscience Corporation's other income (expense) increased by 144.4% year-over-year, from -$394K to $175K.
What is the long-term trend for Twist Bioscience Corporation's other income (expense)?
Over 3 years (2021 to 2024), Twist Bioscience Corporation's other income (expense) has grown at a 25.1% compound annual growth rate (CAGR), from -$1.37M to -$2.68M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.